Advanced Lab Diagnostics in Boca Raton
Everything Looks “Normal” Is Not an Answer
You feel unwell. You have symptoms you can’t explain — fatigue, cognitive fog, poor sleep, reduced performance, weight changes. You see your doctor. Standard labs come back. Everything looks normal. The conversation ends. The symptoms continue.
Standard laboratory panels are designed to catch disease that has already declared itself. They are screening tools calibrated for frank pathology — not for the functional decline, the early metabolic dysfunction, the nutritional depletion, or the hormonal imbalance that precedes that disease by years. The gap between what standard labs measure and what is clinically relevant is exactly where advanced diagnostics operate.
What Advanced Diagnostics Looks Like at BRCM
Advanced Lipid and Cardiovascular Markers
Beyond the standard lipid panel, Dr. Stein assesses LDL particle number and size, lipoprotein(a), apolipoprotein B, high-sensitivity CRP, homocysteine, and oxidized LDL where cardiovascular risk warrants it. These markers collectively provide a far more accurate picture of atherosclerotic risk than total cholesterol or LDL-C alone — and they can identify significant risk in patients whose standard panel looks unremarkable.
Hormonal and Endocrine Assessment
Metabolic and Insulin Resistance Markers
Inflammatory and Immune Markers
Chronic systemic inflammation drives cardiovascular disease, metabolic dysfunction, cognitive decline, and accelerated aging. Dr. Stein evaluates inflammatory status through hsCRP, ferritin, fibrinogen, and, in selected patients, a comprehensive cytokine profile. For members with autoimmune conditions or immune dysfunction, expanded immune panels provide the clinical information that drives appropriate management.
Micronutrient and Nutritional Status
Vitamin D insufficiency, magnesium depletion, B12 and folate status, iron studies — functional micronutrient deficiencies are extremely common in South Florida and frequently missed by standard screening. Optimal vitamin D levels for cardiovascular and immune health are substantially higher than the threshold used to diagnose deficiency. Dr. Stein addresses identified deficiencies with therapeutic intent, not a footnote on a lab report.
Genetic and Pharmacogenomic Testing
For selected members, genetic testing provides clinically actionable information — APOE genotype for cardiovascular and cognitive risk stratification, MTHFR variants affecting folate metabolism and homocysteine elevation, and pharmacogenomic panels identifying how you metabolize specific medication classes. Once obtained, this information is permanently relevant to every treatment decision that follows.



